A client’s leading potential aquisition was being auctioned by a merchant bank, R&S’s analysis showed over-inflated value and potential unreported conflicts in the data presented. Their client passed, and so did the competition. For more details, call 973.726.4858.
A 2nd generation medical device was ready but the 1st generation was still unaccepted in the market, so the principals identified a new use, opening the flood gates. Find out more by calling 973.726.4858.
A large medical device company wanted projections for a new surgical technology. Despite huge hype, R&S’s projected growth curve and analysis suggested a “wait policy” which competitors now wish they had followed. Don’t wait, call now for the whole story 973.726.4858.
A team approach developed a study that unveiled a $1 billion opportunity in the cosmetic procedure market, giving a technology licensing company the confidence to form a new commercialized subsidiary. Learn what was unique about this study: call 973.726.4858.
An R&S segmentation study identified market potential, competitive assessment, and critical mass of the most advantageous entry strategy for a Fortune 100 medical company. Learn how the various entry strategies were significantly different: call 973.726.4858.
Thought leader interviews pointed the way towards a clinical study and the price recommendations proposed by our principals so that payers would accept the fees for a new physician service. Payer, Provider, or Patient—who is the driver in today’s market for your product: call 973.726.4858.
Not every great product is economically viable, but an R&S study, development plan, and analysis cleared the way for a new anti-inflammatory compound. Figure out what made a difference by calling 973.726.4858.
From a list of 100s, six potential synergistic acquisition candidates were identified for a Fortune 100 medical device company. Call 973.726.4858 for the whole scoop on how this was possible.
R&S insights cut through perceptually conflicting information to identify current technology that not only pre-empted proposed applications of industry “thought leaders,” but prevented their client from making a multi-million dollar mistake based on inaccurate conclusions. Ask better questions, get better answers: call 973.726.4858 for all the details.